DTC
Deep Track Capital Portfolio holdings
AUM
$4.38B
1-Year Est. Return
118.22%
This Fund
S&P 500
1 Year Est. Return
+118.22%
AUM
$4.38B
AUM Growth
+$801M
(+22%)
Holding
73
Top Buys
| 1 | +$124M | |
| 2 | +$100M | |
| 3 | +$88.4M | |
| 4 |
Alkermes
ALKS
|
+$59.9M |
| 5 |
Soleno Therapeutics
SLNO
|
+$54.8M |
Top Sells
| 1 | +$190M | |
| 2 | +$159M | |
| 3 | +$155M | |
| 4 |
ETNB
89bio
ETNB
|
+$138M |
| 5 |
Guardant Health
GH
|
+$121M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Immunovant
IMVT
$4.97B
| $293M | 6.68% |
11,526,971
+1,798,126
|
|
||
|
2
Guardant Health
GH
$11.2B
| $286M | 6.52% |
2,800,000
-1,354,086
|
|
||
3
Structure Therapeutics
GPCR
$3.81B
| $286M | 6.52% |
4,111,782
-104,029
|
|
||
4
Tarsus Pharmaceuticals
TARS
$2.89B
| $246M | 5.61% |
3,004,034
+4,034
|
|
||
|
DVAX
5
DELISTED
Dynavax Technologies
DVAX
| $242M | 5.52% |
15,726,349
|
|
||
6
Cytokinetics
CYTK
$7.4B
| $212M | 4.84% |
3,336,998
-963,002
|
|
||
7
Axsome Therapeutics
AXSM
$7.98B
| $210M | 4.79% |
1,150,000
+250,000
|
|
||
8
Apellis Pharmaceuticals
APLS
$2.42B
| $195M | 4.44% |
7,750,000
-250,382
|
|
||
9
Vaxcyte
PCVX
$7.86B
| $185M | 4.21% |
4,000,000
+1,000,000
|
|
||
|
MAZE
10
Maze Therapeutics
MAZE
$2.42B
| $176M | 4.01% |
4,246,440
+297,530
|
|
||
11
Vera Therapeutics
VERA
$2.85B
| $143M | 3.26% |
+2,821,135
|
|
||
12
BioMarin Pharmaceuticals
BMRN
$11.3B
| $137M | 3.12% |
2,300,000
+2,275,144
|
|
||
13
Ionis Pharmaceuticals
IONS
$11.8B
| $134M | 3.07% |
1,700,000
-2,108,144
|
|
||
14
Nurix Therapeutics
NRIX
$1.55B
| $133M | 3.04% |
7,036,455
+979,431
|
|
||
|
MBX
15
MBX Biosciences
MBX
$1.26B
| $102M | 2.34% |
3,249,790
+99,790
|
|
||
16
Ocular Therapeutix
OCUL
$1.91B
| $98M | 2.23% |
8,070,414
-3,861,723
|
|
||
|
GRAL
17
GRAIL Inc
GRAL
$1.74B
| $87.5M | 2% |
+1,022,797
|
|
||
18
Viridian Therapeutics
VRDN
$2.93B
| $78.6M | 1.79% |
2,524,833
-2,855,616
|
|
||
|
LBRX
19
LB Pharmaceuticals
LBRX
$649M
| $74.6M | 1.7% |
3,352,804
|
|
||
20
Immunocore
IMCR
$1.56B
| $69.6M | 1.59% |
2,003,978
+203,978
|
|
||
|
ORKA
21
Oruka Therapeutics
ORKA
$1.94B
| $65.5M | 1.49% |
2,161,510
-493,271
|
|
||
22
BridgeBio Pharma
BBIO
$13.5B
| $62M | 1.41% |
810,142
-389,858
|
|
||
23
CorMedix
CRMD
$510M
| $61.3M | 1.4% |
5,274,076
+4,774,076
|
|
||
24
MoonLake Immunotherapeutics
MLTX
$1.23B
| $60.8M | 1.39% |
+4,610,071
|
|
||
|
25
Alkermes
ALKS
$4.63B
| $56M | 1.28% |
+2,000,000
|
|